Soon after Sanofi Pharmaceuticals’ Inc. August 2012 launch of the biologic drug ziv-aflibercept (brand name Zaltrap) into the U.S. market, its price triggered an unusual act of defiance on the part of oncolAogists. Physicians from Memorial Sloan-Kettering...
Filed under: All Categories, Consumers, Policy, Insurance, Payment, Physicians, Health Care Costs, Medicare, Pharma, Hospitals, Medicaid